We use them to give you the best experience. If you continue using our website, we’ll assume that you are happy to receive all cookies on this website. Kemwell has been providing CDMO services to pharmaceutical and biopharmaceutical clients globally for more than three decades. Kemwell scientists are specialists in dosage form development, including inhaled, nasal, oral, parenteral, and topical. Clients include around 100 global biopharma and pharma organisations, serving seven of the world’s top ten ‘Big Pharma’ companies with development, manufacturing and distribution of small and large molecule products. Kemwell’s pharmaceutical development labs in India and Sweden are led by a management team with the necessary experience, scientific knowledge, vision and steadfast commitment to meet customers’ needs. The management team guides Kemwell’s scientific workforce, which is composed of highly experienced and well-qualified professionals who spearhead resources from India and Sweden to find the best solution for you. Kemwell’s pharmaceutical development labs in India and US are led by a management team with the necessary experience, scientific knowledge, vision and steadfas...